164 related articles for article (PubMed ID: 25654115)
1. Solid phase-based cross-matching as solution for kidney allograft recipients pretreated with therapeutic antibodies.
Schlaf G; Apel S; Wahle A; Altermann WW
Biomed Res Int; 2015; 2015():587158. PubMed ID: 25654115
[TBL] [Abstract][Full Text] [Related]
2. General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases.
Schlaf G; Mauz-Körholz C; Ott U; Leike S; Altermann W
Histol Histopathol; 2012 Jan; 27(1):31-8. PubMed ID: 22127594
[TBL] [Abstract][Full Text] [Related]
3. Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis.
Klein K; Süsal C; Schäfer SM; Becker LE; Beimler J; Schwenger V; Zeier M; Schemmer P; Macher-Goeppinger S; Scherer S; Opelz G; Morath C
Atheroscler Suppl; 2013 Jan; 14(1):199-202. PubMed ID: 23357165
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the established standard complement-dependent cytotoxicity and flow cytometric crossmatch assays with a novel ELISA-based HLA crossmatch procedure.
Altermann WW; Seliger B; Sel S; Wendt D; Schlaf G
Histol Histopathol; 2006 Oct; 21(10):1115-24. PubMed ID: 16835834
[TBL] [Abstract][Full Text] [Related]
5. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch.
Riella LV; Safa K; Yagan J; Lee B; Azzi J; Najafian N; Abdi R; Milford E; Mah H; Gabardi S; Malek S; Tullius SG; Magee C; Chandraker A
Transplantation; 2014 Jun; 97(12):1247-52. PubMed ID: 24854670
[TBL] [Abstract][Full Text] [Related]
7. A novel ELISA-based crossmatch procedure to detect donor-specific anti-HLA antibodies responsible for corneal allograft rejections.
Sel S; Schlaf G; Schurat O; Altermann WW
J Immunol Methods; 2012 Jul; 381(1-2):23-31. PubMed ID: 22561526
[TBL] [Abstract][Full Text] [Related]
8. New crossmatch technique eliminates interference by humanized and chimeric monoclonal antibodies.
Book BK; Agarwal A; Milgrom AB; Bearden CM; Sidner RA; Higgins NG; Pescovitz MD
Transplant Proc; 2005 Mar; 37(2):640-2. PubMed ID: 15848485
[TBL] [Abstract][Full Text] [Related]
9. Successful deceased-donor kidney transplantation in crossmatch-positive patients with peritransplant plasma exchange and Rituximab.
Beimler JH; Morath C; Schmidt J; Ovens J; Opelz G; Rahmel A; Zeier M; Süsal C
Transplantation; 2009 Mar; 87(5):668-71. PubMed ID: 19295310
[TBL] [Abstract][Full Text] [Related]
10. HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance.
Schönemann C; Groth J; Leverenz S; May G
Transplantation; 1998 Jun; 65(11):1519-23. PubMed ID: 9645818
[TBL] [Abstract][Full Text] [Related]
11. Modified flow cytometry crossmatch detecting alloantibody-related cytotoxicity as a way to distinguish lytic antibodies from harmless in allosensitised kidney recipients.
Zieliński M; Zielińska H; Moszkowska G; Dȩbska-Ślizień A; Rutkowski B; Trzonkowski P
Transplant Proc; 2013; 45(1):88-94. PubMed ID: 23375279
[TBL] [Abstract][Full Text] [Related]
12. Superiority of AbCross enzyme-linked immunosorbent assay cross-match over the B-cell complement-dependent lymphocytotoxicity cross-match.
Gombos P; Opelz G; Scherer S; Morath C; Zeier M; Schemmer P; Langer RM; Süsal C
Transplant Proc; 2013 May; 45(4):1383-5. PubMed ID: 23726578
[TBL] [Abstract][Full Text] [Related]
13. Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants.
Kim Y; Yang CW; Moon IS; Kim M; Lim J; Park YJ; Han K; Oh EJ
Ann Clin Lab Sci; 2010; 40(4):330-5. PubMed ID: 20947806
[TBL] [Abstract][Full Text] [Related]
14. Pre-transplant donor specific antibody and its clinical significance in kidney transplantation.
Thammanichanond D; Ingsathit A; Mongkolsuk T; Rattanasiri S; Kantachuvesiri S; Sakhonrat C; Leenanupan C; Worawichawongs S; Kitpoka P
Asian Pac J Allergy Immunol; 2012 Mar; 30(1):48-54. PubMed ID: 22523907
[TBL] [Abstract][Full Text] [Related]
15. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation.
Morris GP; Phelan DL; Jendrisak MD; Mohanakumar T
Hum Immunol; 2010 Mar; 71(3):268-73. PubMed ID: 20074605
[TBL] [Abstract][Full Text] [Related]
16. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation.
Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Hallar M; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Transpl Immunol; 2008 Nov; 20(1-2):61-7. PubMed ID: 18929659
[TBL] [Abstract][Full Text] [Related]
18. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
[TBL] [Abstract][Full Text] [Related]
19. Improved flow cytometry based cytotoxicity and binding assay for clinical antibody HLA crossmatching.
Alheim M; Paul PK; Hauzenberger DM; Wikström AC
Hum Immunol; 2015 Nov; 76(11):849-57. PubMed ID: 26429307
[TBL] [Abstract][Full Text] [Related]
20. Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection.
Hirai T; Kohei N; Omoto K; Ishida H; Tanabe K
Transpl Int; 2012 Sep; 25(9):925-34. PubMed ID: 22764746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
